News

QuickChek – April 26, 2021

Markets
0 min read



Ocugen up over 20% in midday trading

Ocugen shares rise on Friday’s announcement of a $100M Direct Offering

Research, News & Market Data on Ocugen

Watch recent presentation from NobleCon17



Kratos Demonstrates SATCOM Situational Awareness to an Operationally Secure Environment Using Commercial Resources

Kratos Defense & Security Solutions announced that they were the first to successfully exhibit an integrated SATCOM capability providing real-time Situational Awareness to an operationally secure environment

Research, News & Market Data on Kratos



Noble Capital Markets initiates coverage on Stem Holdings

Noble initiates research coverage on Stem Holdings, cannabis cultivator and technology omnichannel retailer with e-commerce ordering and express and next-day delivery

Research, News & Market Data on Driven By Stem



electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation

electroCore, Inc. announced that Johns Hopkins University School of Medicine is starting an investigator-initiated trial of non-invasive vagus nerve stimulation (nVNS) using the Company’s proprietary gammaCore device to treat symptomatic exacerbation of nausea in patients with gastroparesis and related disorders

Research, News & Market Data on electroCore



Avivagen Announces First Purchase Order from Large Integrated Producer in Asia

Avivagen Inc. announced that it has received its first purchase order from a large, integrated livestock producer in Thailand

Noble Capital Markets Senior Research Analyst Joe Gomes’ report

Research, News & Market Data on Avivagen

Watch recent presentation from NobleCon17

Stay up to date. Follow us:

Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.